Asthma in Children

Respiratory
1
Pipeline Programs
4
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
1
Budesonide Formoterol Drug CombinationPhase 31 trial
Active Trials
NCT04705727Terminated102Est. Jun 2023
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Asthma CHAMPS full programN/A1 trial
Active Trials
NCT05814510RecruitingEst. Jun 2027
Providence Therapeutics
1 program
CASE ProgramN/A1 trial
Active Trials
NCT03583814CompletedEst. Aug 2024
Teva
TevaIsrael - Petach Tikva
1 program
Digihaler Albuterol Device by TEVAN/A1 trial
Active Trials
NCT04896645Completed21Est. Jun 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
AstraZenecaBudesonide Formoterol Drug Combination
City TherapeuticsAsthma CHAMPS full program
TevaDigihaler Albuterol Device by TEVA
Providence TherapeuticsCASE Program

Clinical Trials (4)

Total enrollment: 123 patients across 4 trials

NCT04705727AstraZenecaBudesonide Formoterol Drug Combination

Budesonide/Formoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Moderate Asthma Exacerbation

Start: Aug 2021Est. completion: Jun 2023102 patients
Phase 3Terminated
NCT05814510City TherapeuticsAsthma CHAMPS full program

Implementation of Asthma Community Home and School Management Program (Asthma CHAMPS)

Start: Nov 2023Est. completion: Jun 2027
N/ARecruiting
NCT04896645TevaDigihaler Albuterol Device by TEVA

Albuterol Integrated Adherence Monitoring in Children With Asthma

Start: Jun 2021Est. completion: Jun 202221 patients
N/ACompleted
NCT03583814Providence TherapeuticsCASE Program

Rhode Island Asthma Integrated Response Program

Start: Nov 2018Est. completion: Aug 2024
N/ACompleted

Related Jobs in Respiratory

Regional Gene Therapy Consultant - Upper Midwest (IL/WI/MN)

Krystal Biotech
3h ago
$185K - $215K/yr

Regional Gene Therapy Consultant - Southwest (CO/AZ/NM/UT)

Krystal Biotech
3h ago
$185K - $215K/yr

Ausbildung zum Pharmakanten (m/w/d)

Ferring Pharmaceuticals
Kiel, Germany
Yesterday

Marketing Intern – Vertex Iberia (Spain)

Vertex Pharmaceuticals
Madrid, Spain
Yesterday

Sales Rep Neurology Region Leipzig, Halle, Gera, Jena, Weimar DE_G2M110105 - befristet bis 31.03.2027 (all genders)

Sanofi
Berlin
Yesterday

Laboratory Assistant (m/w/d)

Ferring Pharmaceuticals
Kiel, Germany
2d ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 123 patients
4 companies competing in this space

Related Indications

Asthma(378)Pulmonary Disease, Chronic Obstructive(263)Chronic Obstructive Pulmonary Disease(123)Idiopathic Pulmonary Fibrosis(90)COPD(74)Chronic Obstructive Pulmonary Disease (COPD)(38)Pulmonary Embolism(27)Respiratory Syncytial Virus Infections(26)Severe Asthma(21)Lung Diseases, Interstitial(19)